Neuroprotection and Axonal Regeneration Induced by Bone Marrow Mesenchymal Stromal Cells Depend on the Type of Transplant

Mesenchymal stromal cell (MSC) therapy to treat neurodegenerative diseases has not been as successful as expected in some preclinical studies. Because preclinical research is so diverse, it is difficult to know whether the therapeutic outcome is due to the cell type, the type of transplant or the mo...

Full description

Saved in:
Bibliographic Details
Main Authors: María Norte-Muñoz, Fernando Lucas-Ruiz, Alejandro Gallego-Ortega, David García-Bernal, Francisco J. Valiente-Soriano, Pedro de la Villa, Manuel Vidal-Sanz, Marta Agudo-Barriuso
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
Online Access:https://doaj.org/article/a1cc733633bd452d888e2d1bf5ec83b6
Tags: Add Tag
No Tags, Be the first to tag this record!